Secondary prevention of sudden cardiac death
Neal A Chatterjee1, Thomas D Rea2
1Electrophysiology Section, Cardiology Division, University of Washington, Seattle, Washington.
Insights
Sudden cardiac death (SCD) prevention is key. Implantable cardioverter-defibrillators (ICDs) help high-risk patients, but ongoing management and new strategies are vital for improving outcomes and reducing mortality.
Area of Science:
- Cardiology
- Electrophysiology
- Public Health
Background:
- Sudden cardiac death (SCD) poses a significant public health challenge.
- Implantable cardioverter-defibrillators (ICDs) are crucial for secondary prevention in patients with ventricular arrhythmia history.
- These patients face a high risk of recurrent arrhythmias and ICD therapies.
Purpose of the Study:
- To review landmark trials on ICD efficacy in secondary prevention.
- To analyze clinical outcomes, including mode of death in SCD survivors.
- To discuss diagnostic evaluation and invasive electrophysiological management strategies.
Main Methods:
- Literature review of landmark clinical trials.
- Analysis of clinical outcomes and mode of death data.
- Discussion of electrophysiological management, including ICD programming, antiarrhythmic drugs, and catheter ablation.
Main Results:
- ICD therapy is a mainstay for secondary prevention but does not eliminate risk.
- Understanding mode of death in survivors is critical for refining treatment.
- Systematic diagnostic evaluation and tailored electrophysiological management are essential.
Conclusions:
- Further research is needed to advance care for secondary prevention patients.
- Optimizing ICD selection, programming, and adjunctive therapies (drugs, ablation) is crucial.
- Addressing future challenges will improve outcomes for patients at risk of SCD.
Abstract:
The prevention and treatment of sudden cardiac death (SCD) remains a significant public health challenge. For patients with a history of sudden death attributable to ventricular arrhythmia, implantable cardioverter-defibrillator (ICD) therapy is a mainstay of treatment, although these patients remain at high risk for recurrent ventricular arrhythmia and defibrillator therapies. In this review, we summarize landmark clinical trials evaluating the efficacy of ICD therapy in secondary prevention patients, review clinical outcomes including mode of death in survivors of SCD, and highlight the role for systematic diagnostic evaluation. We additionally discuss the invasive electrophysiological management of these patients, including ICD selection and programming as well as the role and timing of antiarrhythmic drug therapy and catheter ablation. Finally, we frame future challenges and needs to advance the care for secondary prevention patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use


